Keywords: adjuvantix, gets, new, funds, drive, vaccine, tech

Adjuvantix gets new funds to drive vaccine tech development

Article | 10 July 2006

In the UK, Biofusion has announced an investment of L240,000 ($442,656) in Adjuvantix, a Sheffield-based biopharmaceutical company focussed on novel technologies ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Sheffield

Go to company listing